Allergic diseases represent a major global health burden, placing significant strain on healthcare systems worldwide. Severe conditions such as anaphylaxis, asthma, food allergy, and allergic rhinitis are driven by immunoglobulin E (IgE), an antibody that binds to immune cells, including mast cells and basophils.
Targeted fab fragments dismantle the allergy trigger
- Post author:admin
- Post published:January 27, 2026
- Post category:uncategorized